Batalini_&_Gulhan_et_al_CCR2022_Sig3_and_PARPi_response
Published: 17 August 2022| Version 1 | DOI: 10.17632/zg5xvm3f3w.1
Contributor:
Felipe BataliniDescription
Data referring to the cohorts used for analytical and clinical validation of Sig3 as biomarker for response to PARPi. Raw sequencing data deposited with dbGaP.
Files
Steps to reproduce
Detailed methods in the appropriate section at the CCR paper.
Institutions
Harvard Medical School
Categories
Clinical Research, Translational Oncology